Bioactivity of Curcumin on the Cytochrome P450 Enzymes of the Steroidogenic Pathway
Open accessPublished version of a preprint
The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Turmeric, a popular ingredient in the cuisine of many Asian countries, comes from the roots of the Curcuma longa and is known for its use in Chinese and Ayurvedic medicine. Turmeric is rich in curcuminoids, including curcumin, demethoxycurcumin, and bisdemethoxycurcumin. Curcuminoids have potent wound healing, anti-inflammatory, and anti-carcinogenic activities. While curcuminoids have been studied for many years, not much is known about their effects on steroid metabolism. Since many anti-cancer drugs target enzymes from the steroidogenic pathway, we tested the effect of curcuminoids on cytochrome P450 CYP17A1, CYP21A2, and CYP19A1 enzyme activities. When using 10 µg/mL of curcuminoids, both the 17α-hydroxylase as well as 17,20 lyase activities of CYP17A1 were reduced significantly. On the other hand, only a mild reduction in CYP21A2 activity was observed. Furthermore, CYP19A1 activity was also reduced up to ~20% of control when using 1–100 µg/mL of curcuminoids in a dose-dependent manner. Molecular docking studies confirmed that curcumin could dock onto the active sites of CYP17A1, CYP19A1, as well as CYP21A2. In CYP17A1 and CYP19A1, curcumin docked within 2.5 Å of central heme while in CYP21A2 the distance from heme was 3.4 Å, which is still in the same range or lower than distances of bound steroid substrates. These studies suggest that curcuminoids may cause inhibition of steroid metabolism, especially at higher dosages. Also, the recent popularity of turmeric powder as a dilatory supplement needs further evaluation for the effect of curcuminoids on steroid metabolism. The molecular structure of curcuminoids could be modified to generate better lead compounds with inhibitory effects on CYP17A1 and CYP19A1 for potential drugs against prostate cancer and breast cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Abiraterone and Increased Survival in Metastatic Prostate Cancer
de Bono, J. S., Logothetis, C. J., Molina, A., Fizazi, K., North, S., Chu, L., Chi, K. N., Jones, R. J., Goodman, O. B., Saad, F., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1014618 · Cited by 4,407
Zanger, U. M., & Schwab, M. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.12.007 · Cited by 4,169 · cited 1×
“Cytochromes P450 enzymes are involved in the biotransformation of drugs, xenobiotics, and steroid hormones [45].”
BackgroundCurcumin: A Review of Its Effects on Human Health
Hewlings, S., & Kalman, D. (2017) · Foods · doi:10.3390/foods6100092 · Cited by 2,720
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
Miller, W. L., & Auchus, R. J. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0013 · Cited by 2,458 · cited 3×
“In the adrenals, CYP21A2 converts progesterone into 11-deoxycorticosterone and 17α-hydroxyprogesterone into 11-deoxycortisol [39].”
BackgroundMultiple biological activities of curcumin: A short review
Maheshwari, R. K., Singh, A. K., Gaddipati, J., & Srimal, R. C. (2006) · Life Sciences · doi:10.1016/j.lfs.2005.12.007 · Cited by 1,674
Androgen Excess in Women: Experience with Over 1000 Consecutive Patients
Azziz, R., Sanchez, L. A., Knochenhauer, E. S., Moran, C., Lazenby, J., Stephens, K. C., Taylor, K., & Boots, L. R. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031122 · Cited by 1,132
Structural basis for androgen specificity and oestrogen synthesis in human aromatase
Ghosh, D., Griswold, J., Erman, M., & Pangborn, W. (2009) · Nature · doi:10.1038/nature07614 · Cited by 618 · cited 1×
“For docking experiments, X-ray crystal structures of human of CYP17A1 (PDB# 3RUK), CYP19A1 (PDB# 3EQM) and CYP21A2 (PDB # 4Y8W), were used [56-58].”
MethodMutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome
Flück, C. E., Tajima, T., Pandey, A. V., Arlt, W., Okuhara, K., Verge, C. F., Jabs, E. W., Mendonça, B. B., Fujieda, K., & Miller, W. L. (2004) · Nature Genetics · doi:10.1038/ng1300 · Cited by 509 · cited 1×
“Androgens regulate sexual differentiation in both the female as well as male and disruption of androgen biosynthesis by mutations in steroid metabolizing enzymes, or their redox partners, cause metabolic disorders [60].”
BackgroundSelf-citationChung, B. C., Picado-Leonard, J., Haniu, M., Bienkowski, M., Hall, P. F., Shively, J. E., & Miller, W. L. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.2.407 · Cited by 444
Multisystem morbidity and mortality in Cushing’s syndrome: a cohort study
Dekkers, O. M., Horváth-Puhó, E., Jørgensen, J. O. L., Cannegieter, S. C., Ehrenstein, V., Vandenbroucke, J. P., Pereira, A. M., & Sørensen, H. T. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3582 · Cited by 419
Chung, B. C., Matteson, K. J., Voutilainen, R., Mohandas, T. K., & Miller, W. L. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.23.8962 · Cited by 354
NADPH P450 oxidoreductase: Structure, function, and pathology of diseases
Pandey, A. V., & Flück, C. E. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.01.010 · Cited by 279 · cited 2×
“The microsomal P450 enzymes metabolize drugs, xenobiotics as well as endogenous substrates, including many steroid hormones like pregnenolone, 17α-hydroxypregnenolone, dehydroepiandrosterone, testosterone, and androstenedione [39,47].”
BackgroundSelf-citationRegulation of 17,20 lyase activity by cytochrome b5 and by serine phosphorylation of P450c17
Pandey, A. V., & Miller, W. L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414673200 · Cited by 165 · cited 4×
“Steroid metabolism by NCI-H295R cells has been studied in our laboratory for many years and culture conditions and passage numbers (kept below 30) adhered to previously established protocols [40,41,55,56,89,90].”
BackgroundMethodInfluentialSelf-citationProtein phosphatase 2A and phosphoprotein SET regulate androgen production by P450c17
Pandey, A. V., Mellon, S. H., & Miller, W. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209527200 · Cited by 137 · cited 2×
“Steroid metabolism by NCI-H295R cells has been studied in our laboratory for many years and culture conditions and passage numbers (kept below 30) adhered to previously established protocols [40,41,55,56,89,90].”
MethodSelf-citationModulation of human CYP19A1 activity by mutant NADPH P450 oxidoreductase
Pandey, A. V., Kempná, P., Hofer, G., Mullis, P. E., & Flück, C. E. (2007) · Molecular Endocrinology · doi:10.1210/me.2007-0245 · Cited by 132 · cited 1×
“From each reaction, 500 μL aliquots were taken for the measurement of radioactivity by scintillation counting using the Rotiszint Universal Cocktail (Carl Roth GmbH, Karlsruhe, Germany), and aromatase activity was calculated as described previously [93,94].”
MethodSelf-citationOmura, T. (2006) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2006.06.008 · Cited by 117
Chung, B. C., Matteson, K. J., & Miller, W. L. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.12.4243 · Cited by 95
Fleseriu, M., & Castinetti, F. (2016) · Pituitary · doi:10.1007/s11102-016-0742-1 · Cited by 87
Research works printed but not linked: 85
- Schraufstatter, 1949, Antibacterial action of curcumin and related compounds, Nature, 164, 456, 10.1038/164456a0 · doi:10.1038/164456a0
- Ammon, 1991, Pharmacology of Curcuma longa, Planta Med., 57, 1, 10.1055/s-2006-960004 · DOI · Paper page
- Parsai, 2014, Analysis of the anticancer activity of curcuminoids, thiotryptophan and 4-phenoxyphenol derivatives, Oncol. Lett., 7, 17, 10.3892/ol.2013.1679 · DOI
- Priyadarsini, 2009, Photophysics, photochemistry and photobiology of curcumin: Studies from organic solutions, bio-mimetics and living cells, J. Photochem. Photobiol. C Photochem. Rev., 10, 81, 10.1016/j.jphotochemrev.2009.05.001 · DOI · Paper page
- Kumar, 2016, Molecular mechanisms underlying chemopreventive potential of curcumin: Current challenges and future perspectives, Life Sci., 148, 313, 10.1016/j.lfs.2016.02.022 · DOI
- Jagetia, 2007, Spicing up of the immune system by curcumin, J. Clin. Immunol., 27, 19, 10.1007/s10875-006-9066-7 · DOI · Paper page
- Han, 2017, Curcuma Longa as Medicinal Herb in the Treatment of Diabetic Complications, Acta Pol. Pharm., 74, 605
- Khaliq, 2015, Recent Progress for the Utilization of Curcuma longa, Piper nigrum and Phoenix dactylifera Seeds against Type 2 Diabetes, West Indian Med. J., 64, 527
- Guo, W., Wu, X., Li, Y., Gao, J., Wang, F., Jin, Y., Chong, T., and Malhotra, A. (2019). Evaluation of biophysical as well as biochemical potential of curcumin and resveratrol during prostate cancer. J. Drug Target., 1–21. · DOI
- Chendil, 2004, Curcumin confers radiosensitizing effect in prostate cancer cell line PC-3, Oncogene, 23, 1599, 10.1038/sj.onc.1207284 · DOI · Paper page
- Nakamura, 2002, Curcumin down-regulates AR gene expression and activation in prostate cancer cell lines, Int. J. Oncol., 21, 825
- Ohtsu, 2002, Antitumor agents. 217. Curcumin analogues as novel androgen receptor antagonists with potential as anti-prostate cancer agents, J. Med. Chem., 45, 5037, 10.1021/jm020200g · DOI · Paper page
- Chen, 2018, Anticancer potential of novel curcumin analogs towards castrate-resistant prostate cancer, Int. J. Oncol., 52, 579
- Zhou, 2016, Pyridine analogues of curcumin exhibit high activity for inhibiting CWR-22Rv1 human prostate cancer cell growth and androgen receptor activation, Oncol. Lett., 11, 4160, 10.3892/ol.2016.4536 · DOI
- Sharma, 2016, Sensitization of androgen refractory prostate cancer cells to anti-androgens through re-expression of epigenetically repressed androgen receptor - Synergistic action of quercetin and curcumin, Mol. Cell. Endocrinol., 431, 12, 10.1016/j.mce.2016.04.024 · DOI
- Mandalapu, 2016, Synthesis and biological evaluation of some novel triazole hybrids of curcumin mimics and their selective anticancer activity against breast and prostate cancer cell lines, Bioorg. Med. Chem. Lett., 26, 4223, 10.1016/j.bmcl.2016.07.053 · DOI
- Jordan, 2016, Molecular mechanisms of curcumin and its semisynthetic analogues in prostate cancer prevention and treatment, Life Sci., 152, 135, 10.1016/j.lfs.2016.03.036 · doi:10.1016/j.lfs.2016.03.036
- Chen, 2015, Curcumin-based anti-prostate cancer agents, Anticancer Agents Med. Chem., 15, 138, 10.2174/1871520615666150116102442 · doi:10.2174/1871520615666150116102442
- Hosseini, 2018, Antidotal or protective effects of Curcuma longa (turmeric) and its active ingredient, curcumin, against natural and chemical toxicities: A review, Biomed. Pharm. Biomed. Pharm., 99, 411, 10.1016/j.biopha.2018.01.072 · DOI
- Anand, 2007, Bioavailability of curcumin: Problems and promises, Mol. Pharm., 4, 807, 10.1021/mp700113r · DOI · Paper page
- Anand, 2008, Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature, Biochem. Pharm., 76, 1590, 10.1016/j.bcp.2008.08.008 · DOI · Paper page
- Mach, 2010, Evaluation of liposomal curcumin cytochrome p450 metabolism, Anticancer Res., 30, 811
- Thangapazham, 2008, Evaluation of a nanotechnology-based carrier for delivery of curcumin in prostate cancer cells, Int. J. Oncol., 32, 1119
- Yallapu, 2012, Design of curcumin loaded cellulose nanoparticles for prostate cancer, Curr. Drug Metab., 13, 120, 10.2174/138920012798356952 · DOI
- Yallapu, 2014, Anti-cancer activity of curcumin loaded nanoparticles in prostate cancer, Biomaterials, 35, 8635, 10.1016/j.biomaterials.2014.06.040 · DOI · Paper page
- Francis, 2015, Future of nano bisdemethoxy curcumin analog: Guaranteeing safer intravenous delivery, Environ. Toxicol. Pharm., 39, 467, 10.1016/j.etap.2014.12.018 · doi:10.1016/j.etap.2014.12.018
- Chang, 2015, Curcumin, encapsulated in nano-sized PLGA, down-regulates nuclear factor kappaB (p65) and subarachnoid hemorrhage induced early brain injury in a rat model, Brain Res., 1608, 215, 10.1016/j.brainres.2015.02.039 · DOI
- Young, N.A., Bruss, M.S., Gardner, M., Willis, W.L., Mo, X., Valiente, G.R., Cao, Y., Liu, Z., Jarjour, W.N., and Wu, L.C. (2014). Oral administration of nano-emulsion curcumin in mice suppresses inflammatory-induced NFkappaB signaling and macrophage migration. PLoS ONE, 9. · DOI
- Ipar, 2019, Enhancing Curcumin Oral Bioavailability Through Nanoformulations, Eur. J. Drug Metab. Pharm., 44, 459, 10.1007/s13318-019-00545-z · DOI · Paper page
- Kushwaha, 2018, Combinatorial drug delivery strategy employing nano-curcumin and nano-MiADMSA for the treatment of arsenic intoxication in mouse, Chem. Biol. Interact., 286, 78, 10.1016/j.cbi.2018.03.006 · doi:10.1016/j.cbi.2018.03.006
- Yu, 2017, A new bioavailability enhancement strategy of curcumin via self-assembly nano-complexation of curcumin and bovine serum albumin, Mater. Sci. Eng. C Mater. Biol. Appl., 75, 25, 10.1016/j.msec.2017.02.018 · doi:10.1016/j.msec.2017.02.018
- Dende, 2017, Nanocurcumin is superior to native curcumin in preventing degenerative changes in Experimental Cerebral Malaria, Sci. Rep., 7, 10062, 10.1038/s41598-017-10672-9 · DOI
- Yan, 2016, Targeted nanomedicine for prostate cancer therapy: Docetaxel and curcumin co-encapsulated lipid-polymer hybrid nanoparticles for the enhanced anti-tumor activity in vitro and in vivo, Drug Deliv., 23, 1757, 10.3109/10717544.2015.1069423 · doi:10.3109/10717544.2015.1069423
- Kuttan, 1985, Potential anticancer activity of turmeric (Curcuma longa), Cancer Lett., 29, 197, 10.1016/0304-3835(85)90159-4 · DOI · Paper page
- Gupta, 2013, Therapeutic roles of curcumin: Lessons learned from clinical trials, Aa. J., 15, 195
- Miyazawa, 2018, Curcumin and piperine supplementation of obese mice under caloric restriction modulates body fat and interleukin-1β, Nutr. Metab., 15, 12, 10.1186/s12986-018-0250-6 · DOI
- Pufall, 2015, Glucocorticoids and Cancer, Adv. Exp. Med. Biol., 872, 315, 10.1007/978-1-4939-2895-8_14 · DOI · Paper page
- Malikova, 2017, CYP17A1 inhibitor abiraterone, an anti-prostate cancer drug, also inhibits the 21-hydroxylase activity of CYP21A2, J. Steroid Biochem. Mol. Biol., 74, 192, 10.1016/j.jsbmb.2017.09.007 · DOI
- Udhane, 2016, Specificity of anti-prostate cancer CYP17A1 inhibitors on androgen biosynthesis, Biochem. Biophys. Res. Commun., 477, 1005, 10.1016/j.bbrc.2016.07.019 · DOI
- Shozu, 1991, A new cause of female pseudohermaphroditism: Placental aromatase deficiency, J. Clin. Endocrinol. Metab., 72, 560, 10.1210/jcem-72-3-560 · DOI · Paper page
- Harada, 1992, Biochemical and molecular genetic analyses on placental aromatase (P-450AROM) deficiency, J. Biol. Chem., 267, 4781, 10.1016/S0021-9258(18)42900-6 · DOI · Paper page
- Simpson, 1994, Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis, Endocr. Rev., 15, 342
- Amalraj, 2017, Biological activities of curcuminoids, other biomolecules from turmeric and their derivatives–A review, J. Tradit. Complement. Med., 7, 205, 10.1016/j.jtcme.2016.05.005 · DOI · Paper page
- Majhi, 2010, Binding of curcumin and its long chain derivatives to the activator binding domain of novel protein kinase C, Bioorganic Med. Chem., 18, 1591, 10.1016/j.bmc.2009.12.075 · DOI
- Mondal, 2016, Stability of curcumin in different solvent and solution media: UV–visible and steady-state fluorescence spectral study, J. Photochem. Photobiol. B Biol., 158, 212, 10.1016/j.jphotobiol.2016.03.004 · DOI
- Yoon, H.J., Zhang, X., Kang, M.G., Kim, G.J., Shin, S.Y., Baek, S.H., Lee, B.N., Hong, S.J., Kim, J.T., and Hong, K. (2018). Cytotoxicity Evaluation of Turmeric Extract Incorporated Oil-in-Water Nanoemulsion. Int. J. Mol. Sci., 19. · DOI
- 2013, Safety and anti-inflammatory activity of curcumin: A component of tumeric (Curcuma longa), J. Altern. Complementary Med., 9, 161
- Gazdar, 1990, Establishment and characterization of a human adrenocortical carcinoma cell line that expresses multiple pathways of steroid biosynthesis, Cancer Res., 50, 5488
- Wang, 2012, Human adrenocortical carcinoma cell lines, Mol. Cell. Endocrinol., 351, 58, 10.1016/j.mce.2011.08.041 · DOI · Paper page
- Samandari, 2007, Human adrenal corticocarcinoma NCI-H295R cells produce more androgens than NCI-H295A cells and differ in 3beta-hydroxysteroid dehydrogenase type 2 and 17,20 lyase activities, J. Endocrinol., 195, 459, 10.1677/JOE-07-0166 · DOI
- Lindholm, 2001, Incidence and late prognosis of cushing’s syndrome: A population-based study, J. Clin. Endocrinol. Metab., 86, 117
- Carmina, 2006, Relative Prevalence of Different Androgen Excess Disorders in 950 Women Referred because of Clinical Hyperandrogenism, J. Clin. Endocrinol. Metab., 91, 2, 10.1210/jc.2005-1457 · DOI · Paper page
- Nakajin, 1984, C21 steroid side chain cleavage enzyme from porcine adrenal microsomes. Purification and characterization of the 17 alpha-hydroxylase/C17,20-lyase cytochrome P-450, J. Biol. Chem., 259, 3971, 10.1016/S0021-9258(17)43191-7 · DOI · Paper page
- Fernandez-Cancio, M., Camats, N., Fluck, C.E., Zalewski, A., Dick, B., Frey, B.M., Monne, R., Toran, N., Audi, L., and Pandey, A.V. (2018). Mechanism of the Dual Activities of Human CYP17A1 and Binding to Anti-Prostate Cancer Drug Abiraterone Revealed by a Novel V366M Mutation Causing 17, 20 Lyase Deficiency. Pharmaceuticals, 11. · DOI
- Kim, 2015, Modulation of Hepatic Cytochrome P450 Enzymes by Curcumin and its Pharmacokinetic Consequences in Sprague-dawley Rats, Pharmacogn. Mag., 11, S580, 10.4103/0973-1296.172965 · DOI
- Sasaki, 2017, Effect of health foods on cytochrome P450-mediated drug metabolism, J. Pharm. Health Care Sci., 3, 14, 10.1186/s40780-017-0083-x · DOI
- Commandeur, 2007, Inhibition of human recombinant cytochrome P450s by curcumin and curcumin decomposition products, Toxicology, 235, 83, 10.1016/j.tox.2007.03.007 · DOI · Paper page
- Montgomery, 2016, Androgen Receptor Modulation Optimized for Response (ARMOR) Phase I and II Studies: Galeterone for the Treatment of Castration-Resistant Prostate Cancer, Clin. Cancer Res., 22, 1356, 10.1158/1078-0432.CCR-15-1432 · DOI
- Fizazi, 2015, NMulticenter Trial Comparing Orteronel (TAK-700) Plus Prednisone With Placebo Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer That Has Progressed During or After Docetaxel-Based Therapy: ELM-PC 5, J. Clin. Oncol., 33, 723, 10.1200/JCO.2014.56.5119 · DOI · Paper page
- Kaku, 2011, Discovery of orteronel (TAK-700), a naphthylmethylimidazole derivative, as a highly selective 17,20-lyase inhibitor with potential utility in the treatment of prostate cancer, Bioorganic Med. Chem., 19, 6383, 10.1016/j.bmc.2011.08.066 · DOI
- Guan, 2017, Therapeutic effects of curcumin nanoemulsions on prostate cancer, J. Huazhong Univ. Sci. Technol. Med. Sci., 37, 371, 10.1007/s11596-017-1742-8 · doi:10.1007/s11596-017-1742-8
- Wang, 1997, Stability of curcumin in buffer solutions and characterization of its degradation product, J. Pharm. Biomed. Anal., 15, 1867, 10.1016/S0731-7085(96)02024-9 · DOI · Paper page
- Dahll, 1994, Photocytotoxicity of curcumin, Photochem. Photobiol., 59, 290, 10.1111/j.1751-1097.1994.tb05036.x · doi:10.1111/j.1751-1097.1994.tb05036.x
- Yuan, 2014, Self-Assembled Nanoparticles of Glycyrrhetic Acid-Modified Pullulan as a Novel Carrier of Curcumin, Molecules, 19, 13305, 10.3390/molecules190913305 · DOI
- Shoba, 1998, Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers, Planta Med., 64, 353, 10.1055/s-2006-957450 · DOI · Paper page
- Delecroix, 2017, Curcumin and Piperine Supplementation and Recovery Following Exercise Induced Muscle Damage: A Randomized Controlled Trial, J. Sports Sci. Med., 16, 147
- Srivilai, 2017, Anti-androgenic curcumin analogues as steroid 5-alpha reductase inhibitors, Med. Chem. Res., 26, 1550, 10.1007/s00044-017-1869-y · DOI
- Changtam, 2010, Curcuminoid analogs with potent activity against Trypanosoma and Leishmania species, Eur. J. Med. Chem., 45, 941, 10.1016/j.ejmech.2009.11.035 · DOI · Paper page
- Parohan, 2019, The synergistic effects of nano-curcumin and coenzyme Q10 supplementation in migraine prophylaxis: A randomized, placebo-controlled, double-blind trial, Nutr. Neurosci., 26, 1
- Rezayat, 2019, Nano-curcumin improves glucose indices, lipids, inflammation, and Nesfatin in overweight and obese patients with non-alcoholic fatty liver disease (NAFLD): A double-blind randomized placebo-controlled clinical trial, Nutr. Metab. (Lond.), 16, 8, 10.1186/s12986-019-0331-1 · DOI · Paper page
- Asadi, 2019, Nano curcumin supplementation reduced the severity of diabetic sensorimotor polyneuropathy in patients with type 2 diabetes mellitus: A randomized double-blind placebo-controlled clinical trial, Complement Ther. Med., 43, 253, 10.1016/j.ctim.2019.02.014 · DOI · Paper page
- Corson, 2007, Molecular understanding and modern application of traditional medicines: Triumphs and trials, Cell, 130, 769, 10.1016/j.cell.2007.08.021 · DOI · Paper page
- Kohler, 1971, Isolation of Hormone-Producing Clonal Lines of Human Choriocarcinoma1, J. Clin. Endocrinol. Metabol., 32, 683, 10.1210/jcem-32-5-683 · DOI · Paper page
- Bird, 1993, Human NCI-H295 adrenocortical carcinoma cells: A model for angiotensin-II-responsive aldosterone secretion, Endocrinology, 133, 1555, 10.1210/endo.133.4.8404594 · doi:10.1210/endo.133.4.8404594 · Paper page
- Rainey, 1994, The NCI-H295 cell line: A pluripotent model for human adrenocortical studies, Mol. Cell. Endocrinol., 100, 45, 10.1016/0303-7207(94)90277-1 · DOI · Paper page
- Udhane, 2015, Retinoic acid receptor beta and angiopoietin-like protein 1 are involved in the regulation of human androgen biosynthesis, Sci. Rep., 5, 10132, 10.1038/srep10132 · DOI · Paper page
- Shaw, 2002, Preferential transformation of human neuronal cells by human adenoviruses and the origin of HEK 293 cells, FASEB J., 16, 869, 10.1096/fj.01-0995fje · DOI · Paper page
- Phattanawasin, 2009, Validated TLC-Image Analysis Method for Simultaneous Quantification of Curcuminoids in Curcuma longa, Chromatographia, 69, 397, 10.1365/s10337-008-0893-y · doi:10.1365/s10337-008-0893-y
- Lephart, 1991, Assay of aromatase activity, Methods Enzymol., 206, 477, 10.1016/0076-6879(91)06116-K · DOI · Paper page
- Krieger, 2004, Making optimal use of empirical energy functions: Force-field parameterization in crystal space, Proteins, 57, 678, 10.1002/prot.20251 · DOI · Paper page
- DeVore, 2012, Structures of cytochrome P450 17A1 with prostate cancer drugs abiraterone and TOK-001, Nature, 482, 116, 10.1038/nature10743 · DOI · Paper page
- Pallan, 2015, Human Cytochrome P450 21A2, the Major Steroid 21-Hydroxylase: Structure of the enzyme·progesterone substrate complex and rate-limiting c–h bond cleavage, J. Biol. Chem., 290, 13128, 10.1074/jbc.M115.646307 · DOI · Paper page
- Trott, 2010, AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading, J. Comput. Chem., 31, 455, 10.1002/jcc.21334 · DOI · Paper page
- Wang, 2019, Nano-Curcumin Simultaneously Protects the Blood-Brain Barrier and Reduces M1 Microglial Activation During Cerebral Ischemia-Reperfusion Injury, ACS Appl. Mater. Interfaces, 11, 3763, 10.1021/acsami.8b20594 · DOI
- Jaguezeski, 2019, Effect of free and nano-encapsulated curcumin on treatment and energetic metabolism of gerbils infected by Listeria monocytogenes, Microb. Pathog., 134, 103564, 10.1016/j.micpath.2019.103564 · DOI
Cited by
Curcumin: Biological Activities and Modern Pharmaceutical Forms
Urošević, M., Nikolić, L., Gajić, I., Nikolić, V., Dinić, A., & Miljković, V. (2022) · Antibiotics · doi:10.3390/antibiotics11020135 · Cited by 347
Biased cytochrome P450-mediated metabolism via small-molecule ligands binding P450 oxidoreductase
Jensen, S. B., Thodberg, S., Parween, S., Moses, M. E., Hansen, C. C., Thomsen, J., Sletfjerding, M. B., Knudsen, C., Del Giudice, R., Lund, P. M., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22562-w · Cited by 64
Self-citationOlivares-Vicente, M., & Herranz-López, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178544 · Cited by 59
“This is achieved by enhancing the production of anti-inflammatory epoxyeicosatrienoic acids (EETs) through cytochrome P450 epoxygenase, while simultaneously preventing their degradation via the inhibition of soluble epoxide hydrolase [157–159].”
Parween, S., DiNardo, G., Baj, F., Zhang, C., Gilardi, G., & Pandey, A. V. (2020) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.105507 · Cited by 39
Self-citationRojas Velazquez, M. N., Noebauer, M., & Pandey, A. V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231710141 · Cited by 11
Self-citation
Metadata
- Authors
- Castaño, P. R., Parween, S., & Pandey, A. V.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2019-09-17
- Volume
- 20
- Issue
- 18
- Pages
- 4606
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W2973896424
- Cited by
- 72
- References
- 18
- FWCI
- 2.43
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.